LAB Q4 2025 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$388M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3M-93.1% YoY

Gross Profit

$3M83.5% margin

Operating Income

-$11M-346.7% margin

Net Income

$19M598.5% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

-83.5%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$568M

Total Liabilities

$143M

Stockholders' Equity

$424M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$47M	-93.1%
Gross Profit	$3M	$22M	-87.7%
Operating Income	-$11M	-$33M	+66.0%
Net Income	$19M	-$34M	+156.6%